title: Recent biological trends in management of fracture non-union.
abstract: Bone regeneration is a complex, well-orchestrated physiological process of bone formation, which can be seen during normal fracture healing, and is involved in continuous remodelling throughout adult life. Currently, there is a plethora of different strategies to augment the impaired or "insufficient" bone-regeneration process, including the "gold standard" autologous bone graft, free fibula vascularised graft, allograft implantation, and use of growth factors, osteoconductive scaffolds, osteoprogenitor cells and distraction osteogenesis. Improved "local" strategies in terms of tissue engineering and gene therapy, or even "systemic" enhancement of bone repair, are under intense investigation, in an effort to overcome the limitations of the current methods, to produce bone-graft substitutes with biomechanical properties that are as identical to normal bone as possible, to accelerate the overall regeneration process, or even to address systemic conditions, such as skeletal disorders and osteoporosis. An improved understanding of the molecular and cellular events that occur during bone repair and remodeling has led to the development of biologic agents that can augment the biological microenvironment and enhance bone repair. Orthobiologics, including stem cells, osteoinductive growth factors, osteoconductive matrices, and anabolic agents, are available clinically for accelerating fracture repair and treatment of compromised bone repair situations like delayed unions and nonunions. A lack of standardized outcome measures for comparison of biologic agents in clinical fracture repair trials, frequent off-label use, and a limited understanding of the biological activity of these agents at the bone repair site have limited their efficacy in clinical applications.
authors.affiliation: Khaled M Emara, Ramy Ahmed Diab, Department of Orthopaedic Surgery, Ain Shams University, Cairo 11511, Egypt.
authors.forename: Khaled M
authors.initials: KM
authors.lastname: Emara
authors.affiliation: Khaled M Emara, Ramy Ahmed Diab, Department of Orthopaedic Surgery, Ain Shams University, Cairo 11511, Egypt.
authors.forename: Ramy Ahmed
authors.initials: RA
authors.lastname: Diab
authors.affiliation: Khaled M Emara, Ramy Ahmed Diab, Department of Orthopaedic Surgery, Ain Shams University, Cairo 11511, Egypt.
authors.forename: Ahmed Khaled
authors.initials: AK
authors.lastname: Emara
keywords: Biological; Bone substitutes; Cell therapy; Fracture repair; Nonunion